REGENXBIO INC (RGNX) Stock Analyst Earnings Estimates
NASDAQ:RGNX - Nasdaq - US75901B1070 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 470.3M 204.20% | 112.7M -76.04% | 90.242M -19.93% | 92.255M 2.23% | 323.6M 250.77% | 190.98M -40.98% | 408.39M 113.84% | 593.78M 45.40% | 814.16M 37.11% | 1.011B 24.18% | 1.272B 25.82% | 1.289B 1.34% | |
| EBITDA YoY % growth | 169.6M 253.07% | -250M -247.41% | -250.808M -0.32% | -229.53M 8.48% | 5.782M 102.52% | -106.356M -1,939.44% | -31.161M 70.70% | 22.43M 171.98% | 88.097M 292.76% | 145.26M 64.89% | N/A | N/A | |
| EBIT YoY % growth | 160M 234.23% | -262.9M -264.31% | -268.128M -1.99% | -246.388M 8.11% | -32.018M 87.01% | -152.087M -375.01% | -112.356M 26.12% | -26.098M 76.77% | 187.9M 819.97% | 436.11M 132.10% | 502.96M 15.33% | 493.61M -1.86% | |
| Operating Margin | 34.02% | -233.27% | -297.12% | -267.07% | -9.89% | -79.64% | -27.51% | -4.40% | 23.08% | 43.14% | 39.54% | 38.29% | |
| EPS YoY % growth | 2.74 197.86% | -6.50 -337.23% | -6.03 7.23% | -4.90 18.74% | -1.27 74.16% | -4.31 -240.13% | -1.90 55.95% | 0.51 126.88% | 4.63 808.00% | 7.45 60.79% | 7.88 5.89% | 7.29 -7.50% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.16 18.76% | -1.16 13.15% | 1.57 249.79% | -0.87 25.90% | -0.86 26.24% | -1.62 -40.40% | -1.50 -195.33% | -1.54 -77.65% | 0.22 126.19% |
| Revenue Q2Q % growth | 23.846M 7.35% | 21.196M 35.68% | 162.51M 628.91% | 47.371M 95.77% | 47.6M 99.61% | 21.42M 1.06% | 22.44M -86.19% | 25.5M -46.17% | 131.58M 176.43% |
| EBITDA Q2Q % growth | -63.039M -35.33% | -50.735M 11.89% | -55.049M -15.15% | 45.135M 190.48% | -50.164M 20.42% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -64.59M -1.08% | -61.853M -0.15% | 59.929M 206.95% | -36.82M 40.69% | -34.17M 47.10% | -86.7M -40.17% | -88.74M -248.08% | -91.8M -149.32% | 6.12M 117.91% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.17 17.02% | -1.14 | -0.03 | -2.21% |
| Q2 2024 Q2Q % growth | -1.05 36.75% | -1.32 | 0.27 | 20.28% |
| Q1 2024 Q2Q % growth | -1.33 13.07% | -1.28 | -0.05 | -3.57% |
| Q4 2023 Q2Q % growth | -1.43 -3.62% | -1.30 | -0.13 | -10.34% |
| Q3 2023 Q2Q % growth | -1.41 19.43% | -1.55 | 0.14 | 8.92% |
| Q2 2023 Q2Q % growth | -1.66 -5.06% | -1.41 | -0.25 | -17.51% |
| Q1 2023 Q2Q % growth | -1.53 14.53% | -1.57 | 0.04 | 2.39% |
| Q4 2022 Q2Q % growth | -1.38 -120.69% | -1.26 | -0.12 | -9.61% |
| Q3 2022 Q2Q % growth | -1.75 -27.74% | -1.49 | -0.26 | -17.40% |
| Q2 2022 Q2Q % growth | -1.58 -16.18% | -1.56 | -0.02 | -1.43% |
| Q1 2022 Q2Q % growth | -1.79 -49.17% | -1.34 | -0.45 | -33.35% |
| Q4 2021 Q2Q % growth | 6.67 637.90% | 4.81 | 1.86 | 38.79% |
| Q3 2021 Q2Q % growth | -1.37 -418.60% | -1.10 | -0.27 | -24.56% |
| Q2 2021 Q2Q % growth | -1.36 -49.45% | -1.14 | -0.22 | -19.51% |
| Q1 2021 Q2Q % growth | -1.20 -11.11% | -1.31 | 0.11 | 8.29% |
| Q4 2020 Q2Q % growth | -1.24 -72.22% | -0.44 | -0.80 | -179.92% |
| Q3 2020 Q2Q % growth | 0.43 145.74% | -1.03 | 1.46 | 141.67% |
| Q2 2020 Q2Q % growth | -0.91 -2,175.00% | -0.90 | -0.01 | -0.69% |
| Q1 2020 Q2Q % growth | -1.08 -21.35% | -0.89 | -0.19 | -21.70% |
| Q4 2019 Q2Q % growth | -0.72 | -0.45 | -0.27 | -60.43% |
| Q3 2019 Q2Q % growth | -0.94 | -0.73 | -0.21 | -29.07% |
| Q2 2019 Q2Q % growth | -0.04 | -0.62 | 0.58 | 93.59% |
| Q1 2019 Q2Q % growth | -0.89 | -0.88 | -0.01 | -1.17% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 24.197M -16.31% | 24.06M | 137K | 0.57% |
| Q2 2024 Q2Q % growth | 22.295M 11.60% | 23.432M | -1.137M | -4.85% |
| Q1 2024 Q2Q % growth | 15.622M -18.37% | 23.995M | -8.373M | -34.89% |
| Q4 2023 Q2Q % growth | 22.213M -29.03% | 34.679M | -12.466M | -35.95% |
| Q3 2023 Q2Q % growth | 28.914M 9.11% | 26.687M | 2.227M | 8.34% |
| Q2 2023 Q2Q % growth | 19.977M -38.72% | 35.195M | -15.218M | -43.24% |
| Q1 2023 Q2Q % growth | 19.138M -13.79% | 31.208M | -12.07M | -38.68% |
| Q4 2022 Q2Q % growth | 31.3M -92.15% | 38.2M | -6.9M | -18.06% |
| Q3 2022 Q2Q % growth | 26.5M -13.96% | 31.428M | -4.928M | -15.68% |
| Q2 2022 Q2Q % growth | 32.6M 48.18% | 27.322M | 5.278M | 19.32% |
| Q1 2022 Q2Q % growth | 22.2M 17.46% | 29.792M | -7.592M | -25.48% |
| Q4 2021 Q2Q % growth | 398.7M 1,763.08% | 277.17M | 121.53M | 43.85% |
| Q3 2021 Q2Q % growth | 30.8M -68.86% | 42.294M | -11.494M | -27.18% |
| Q2 2021 Q2Q % growth | 22M 32.53% | 29.603M | -7.603M | -25.68% |
| Q1 2021 Q2Q % growth | 18.9M 7.39% | 23.697M | -4.797M | -20.24% |
| Q4 2020 Q2Q % growth | 21.4M 81.36% | 62.733M | -41.333M | -65.89% |
| Q3 2020 Q2Q % growth | 98.9M 572.79% | 21.793M | 77.107M | 353.82% |
| Q2 2020 Q2Q % growth | 16.6M 110.13% | 22.511M | -5.911M | -26.26% |
| Q1 2020 Q2Q % growth | 17.6M 1,855.56% | 18.819M | -1.219M | -6.48% |
| Q4 2019 Q2Q % growth | 11.8M | 40.463M | -28.663M | -70.84% |
| Q3 2019 Q2Q % growth | 14.7M | 10.747M | 3.953M | 36.78% |
| Q2 2019 Q2Q % growth | 7.9M | 17.316M | -9.416M | -54.38% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -2.95% | 4.29% | -0.21% | -1.76% |
| Revenue | -0.37% | -0.37% | 0% | -4.62% |